TORQUE’S GLIMTOR M2

Torque’s Glimtor M2 Tablets contains Metformin, a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose and Glimepiride, a sulphonylurea antihyperglycaemic agent acts mainly by stimulating insulin release from pancreatic beta cells.

Categories: ,

Product Description

Description: Torque’s Glimtor M2 Tablets contains Metformin, a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose and Glimepiride, a sulphonylurea antihyperglycaemic agent acts mainly by stimulating insulin release from pancreatic beta cells.

Pharmaceutical Dosage Form: Tablet

Route of Administration: Oral

Composition:

Each uncoated bilayered tablet contains:

Metformin Hydrochloride IP            500 mg

(As Prolonged Release)

Glimepiride IP                                1 mg

Excipients                                       q.s.

Mechanism of Action: Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Glimepiride primarily lowers blood glucose by stimulating the release of insulin from pancreatic beta-cells. It binds to the sulphonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin.

Indications: Torque’s Glimtor M2 is indicated for the treatment of patients with type II diabetes mellitus when diet, exercise and single agent does not result in adequate glycemic control.

Dosage: As directed by the physician.

Storage: Store at a temperature not exceeding 30°C, protected from light & moisture.

Presentation: 15 x 2 x 15

Side effects: The following adverse reactions may occur:

Lactic Acidosis

Taste Disturbance

Nausea

Vomiting

Diarrhoea

Abdominal Pain

Loss of Appetite

Contraindications:

Torque’s Glimtor M2 is contraindicated in patients with:

Known hypersensitivity to metformin, glimepiride or any of the components of this product.

Severe renal impairment

Acute or chronic metabolic acidosis, including diabetic ketoacidosis and lactic acidosis

Diabetic pre-coma

An allergic reaction to sulphonamide derivatives may develop an allergic reaction

Hepatic insufficiency, acute alcohol intoxication, alcoholism

Insulin dependent diabetes

Drug Interactions:

Alcohol

NSAIDs

ACE Inhibitors

Angiotensin II Receptor Antagonists

Diuretics

Verapamil

Rifampicin

Cimetidine, Dolutegravir, Ranolazine, Trimethoprime,

Isavuconazole, Fluconazole

Vandetanib, Crizotinib, Olaparib

Thyroid Stimulating Agents, Glucocorticoids

Anabolic Steroids and Male Sex Hormones